Design Therapeutics マネジメント
マネジメント 基準チェック /24
Design Therapeutics' CEO is Pratik Shah, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is $6.32M, comprised of 5.7% salary and 94.3% bonuses, including company stock and options. directly owns 0.23% of the company’s shares, worth $675.59K. The average tenure of the management team and the board of directors is 3.2 years and 4 years respectively.
主要情報
Pratik Shah
最高経営責任者
US$6.3m
報酬総額
| CEO給与比率 | 5.7% |
| CEO在任期間 | 1.3yrs |
| CEOの所有権 | 0.2% |
| 経営陣の平均在職期間 | 3.2yrs |
| 取締役会の平均在任期間 | 4yrs |
経営陣の近況
Recent updates
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Oct 04
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Jun 19Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Mar 15Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Nov 16Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation
Jun 06Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans
Feb 09Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Oct 25Design Therapeutics GAAP EPS of -$0.27 misses by $0.02
Aug 08We're Not Very Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Rate
Jul 02Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Mar 18Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
Dec 03Here's Why We're Not Too Worried About Design Therapeutics' (NASDAQ:DSGN) Cash Burn Situation
Aug 18Design Therapeutics expands board of directors
Jun 07Design Therapeutics EPS misses by $0.24
May 10CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$59m |
| Dec 31 2023 | US$6m | US$361k | -US$67m |
| Sep 30 2023 | n/a | n/a | -US$72m |
| Jun 30 2023 | n/a | n/a | -US$74m |
| Mar 31 2023 | n/a | n/a | -US$69m |
| Dec 31 2022 | US$5m | US$338k | -US$63m |
| Sep 30 2022 | n/a | n/a | -US$57m |
| Jun 30 2022 | n/a | n/a | -US$51m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$585k | US$310k | -US$36m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$19m |
| Mar 31 2021 | n/a | n/a | -US$13m |
| Dec 31 2020 | US$400k | US$250k | -US$8m |
報酬と市場: Pratik's total compensation ($USD6.32M) is above average for companies of similar size in the US market ($USD1.48M).
報酬と収益: Pratik's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Pratik Shah (54 yo)
1.3yrs
在職期間
US$6,317,780
報酬
Dr. Pratik Shah, Ph D., is an Executive Chairperson at Design Therapeutics, Inc. since December 2017 and serves as its President, Chief Executive Officer and Principal Financial Officer since August 25, 20...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 1.3yrs | US$6.32m | 0.23% $ 675.6k | |
| Chief Operating Officer | 3.8yrs | US$1.28m | 1.44% $ 4.2m | |
| Co-Founder & Scientific Advisor | no data | データなし | 13.54% $ 39.9m | |
| Chief Accounting Officer | 3.2yrs | データなし | データなし | |
| General Counsel | no data | データなし | データなし | |
| Consulting Chief Medical Officer | 2.8yrs | データなし | 0.0084% $ 24.7k | |
| Controller | 4.6yrs | データなし | データなし |
3.2yrs
平均在職期間
54yo
平均年齢
経験豊富な経営陣: DSGN's management team is considered experienced (3.2 years average tenure).
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 6.9yrs | US$6.32m | 0.23% $ 675.6k | |
| Co-Founder & Scientific Advisor | no data | データなし | 13.54% $ 39.9m | |
| Independent Director | 4yrs | US$106.70k | 0.10% $ 299.7k | |
| Independent Director | 5.3yrs | US$228.56k | 0.23% $ 691.7k | |
| Lead Independent Director | 4.8yrs | US$95.70k | 0% $ 0 | |
| Independent Director | 3.4yrs | US$94.20k | 0.042% $ 123.8k | |
| Independent Director | 3.4yrs | US$94.20k | 0.0023% $ 6.8k | |
| Independent Director | 3.8yrs | US$104.20k | 0% $ 0 |
4.0yrs
平均在職期間
49yo
平均年齢
経験豊富なボード: DSGN's board of directors are considered experienced (4 years average tenure).